Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients

BACKGROUND: Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of survivin expression in advanced stages ovarian cancer with respect to the TP53...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Felisiak-Golabek, Anna, Rembiszewska, Alina, Rzepecka, Iwona K, Szafron, Lukasz, Madry, Radoslaw, Murawska, Magdalena, Napiorkowski, Tomasz, Sobiczewski, Piotr, Osuch, Beata, Kupryjanczyk, Jolanta
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2011
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223127/
https://ncbi.nlm.nih.gov/pubmed/22075440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-4-20
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items